The CML THERAPY brand, founded in 2012 (United States), from 496 sister brands and 17477 competing brands. The CML THERAPY brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. CML THERAPY belongs to the Drug Manufacturers business sector.

CML THERAPY is a brand of BRISTOL-MYERS SQUIBB COMPANY (BMY) Share price

Share price and profitability of the share BRISTOL-MYERS SQUIBB COMPANY (CML THERAPY)

Buy BRISTOL-MYERS SQUIBB COMPANY share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 54.23

Portfolio valuation
BRISTOL-MYERS SQUIBB COMPANY (CML THERAPY) over 5 years* USD 62.45

Stock market history BRISTOL-MYERS SQUIBB COMPANY (CML THERAPY)